Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study
Classic

Breast cancer screening in Denmark: a cohort study of tumor size and overdiagnosis.

Jørgensen KJ, Gøtzsche PC, Kalager M, Zahl PH. Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis. Ann Intern Med. 2017;166(5):313-323. doi:10.7326/M16-0270

Save
Print
January 25, 2017
Jørgensen KJ, Gøtzsche PC, Kalager M, et al. Ann Intern Med. 2017;166(5):313-323.
View more articles from the same authors.

The overuse of medical care is increasingly recognized as a patient safety issue. Overdiagnosis can result in unnecessary use of medical care, subjecting patients to greater risk of harm. For example, in the case of breast cancer, screening may detect lesions that are not clinically significant, leading to further testing and unnecessary procedures. This study examined the impact of mammography screening on a cohort of women in Denmark. Researchers found that screening was not associated with decreased incidence of advanced cancer but increased incidence of nonadvanced tumors and ductal carcinoma in situ; the rate of overdiagnosis was significant. An accompanying editorial discusses overdiagnosis in breast cancer.

Save
Print
Cite
Citation

Jørgensen KJ, Gøtzsche PC, Kalager M, Zahl PH. Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis. Ann Intern Med. 2017;166(5):313-323. doi:10.7326/M16-0270

Related Resources From the Same Author(s)
Related Resources